Japan's Eisai to Cut 450 U.S. Jobs in "Realignment"

Apr 10, 2015

Reuters

Tokyo-based Eisai Co announced it will cut about 25 percent --450 jobs -- in the U.S. as part of a realignment effort to increase efficiency.

Eisai has U.S. locations in New Jersey, North Carolina, Massachusetts, Pennsylvania and Maryland. The layoffs, according to FierceBiotech, will be made before the end of April and will eliminate "various" parts of the company's 1,800 U.S. workers.

Eisai, which began with a two-brand structure built on anti-Alzheimer's drug Aricept and acid reflux treatment Pariet, expanded its portfolio to launch oncology, epilepsy and obesity treatments, including well-know drugs such as Humira, Lyrica and Belviq.

Read the Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments